Beware of boilerplate: Practical lessons for patent drafting from G1/24 (Claim interpretation)
Following the high profile hearing last month, we are now all waiting with bated breath for the written decision of the Enlarged Board of...
top of page
G 2/21 applied to software inventions (T 0687/22)
The EPO Board of Appeal decision in T 0687/22 confirms beyond doubt the relevance of G 2/21 to software inventions. The decision in ...
Too broad, too early? AI platform for cell analysis found to lack technical character and sufficiency (T 0660/22, Cell analysis/NIKON)
The decision in T 0660/22 combines two hot topics, AI and cells! The patent application at issue related to a method for analysing...
AlphaFold: From Nobel Prize to drug-discovery gold mine?
AlphaFold, a machine learning model for predicting protein structure, is arguably one of the greatest achievements of AI so far. Whilst...
OpenAI's large language model (LLM) patents
OpenAI's approach to IP is often cited in the tech industry as an example of a radically new approach to IP. OpenAI has the reputation...
IP strategy for AI-assisted drug discovery
AI has been hailed as a potentially revolutionary tool for accelerating and enhancing the difficult and expensive process of drug...
bottom of page